BUSULFEX
Live / Registered — Registered and renewed (as of 20 Jun 2019)
What this means for you
Registered since 15 Jun 1999. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 15 Jun 2019).
Record
- Serial number
- 75252920
- Registration number
- 2254101
- Mark type
- Word mark
- Filed
- 06 Mar 1997
- Published for opposition
- 02 Dec 1997
- Registered
- 15 Jun 1999
- Next maintenance due
- 15 Jun 2019
- Attorney of record
- Scott S. Havlick
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical perparation for use as a preparatory regime in connection with bone marrow transplants
Owner
- OTSUKA PHARMACEUTICAL CO., LTD., CHIYODA-KU, TOKYO, JP
- ESP PHARMA, INC., EDISON, NJ, US
- Orphan Medical, Inc., Minnetonka, MN, US
- Orphan Medical, Inc., Minnetonka, MN, US
- Orphan Medical, Inc., Minnetonka, MN, US
Prosecution history
- 20 Jun 2019 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 20 Jun 2019 — REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
- 20 Jun 2019 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 20 Jun 2019 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 13 May 2019 — TEAS SECTION 8 & 9 RECEIVED
- 15 Jun 2018 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 04 May 2009 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 04 May 2009 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 04 May 2009 — ASSIGNED TO PARALEGAL
- 28 Apr 2009 — TEAS SECTION 8 & 9 RECEIVED
- 03 Mar 2009 — CASE FILE IN TICRS
- 19 Mar 2008 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 10 Aug 2004 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 06 Jul 2004 — REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
- 06 Jul 2004 — TEAS SECTION 8 & 15 RECEIVED